Sleep Disorders Trial, Recruiting NCT07331285 Sponsor: Nyxoah Inc. Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07331285
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a sleep apnea severity score (called an AHI) between 15 and 65, confirmed by an overnight sleep study done within the last 2 years, with specific measurements recorded (AHI4 and ODI4).
  • Adults aged 22 years or older.
  • People whose moderate to severe sleep apnea has not responded to, has not been tolerated by, or is not suitable for standard sleep apnea treatments.
  • People who have applied for insurance pre-approval for the Genio® Therapy device, or who are willing to cover any out-of-pocket costs themselves (the trial sponsor will not cover treatment costs).
  • People who agree to take part voluntarily and sign and date a consent form.
  • People who are willing and able to follow all study requirements, including lifestyle considerations, attending all follow-up visits, and completing all assessments and questionnaires for the full duration of the trial.
  • People who have had a specific sleep procedure called a Drug-Induced Sleep Endoscopy (DISE) — a test done while lightly sedated to observe the airway — within the last 2 years (confirm with trial site).

Who may not be able to join:

  • People whose sleep apnea events are made up of 25% or more of a type called central or mixed apneas, rather than the obstructive type.
  • People with a physical or medical condition that could prevent or interfere with the implantation, activation, or ongoing use of the Genio® device.
  • People who already have an implanted medical device that could interact in an unintended way with the Genio® System 2.1 (confirm with trial site).
  • People who are pregnant, planning to become pregnant, or currently breastfeeding.
  • People with any condition or procedure that has affected nerve control of the upper airway.
  • People outside the age range of 22 to 75 years.
  • People with a Body Mass Index (BMI) — a measure of body weight relative to height — above 32 kg/m².
  • People with an AHI sleep apnea score below 15 or above 65 events per hour.
  • People whose sleep study showed a specific pattern of airway collapse called Complete Concentric Collapse at the soft palate level (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1 (908) 263-0228

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nyxoah Inc.
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Apnea Hypopnea Index (AHI4%); Change in Oxyhemoglobin Desaturation Index (ODI4%); Device related SAEs; Device-related and procedure-related SAEs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov